Amgen (NASDAQ:AMGN) Price Target Increased to $290.00 by Ana

Amgen (NASDAQ:AMGN – Get Rating) had its target price increased by Oppenheimer from $285.00 to $290.00 in a research note issued to investors on Wednesday morning, The Fly reports. Other equities analysts also recently issued research reports about the stock. StockNews.com upgraded shares of Amgen from a buy rating to a strong-buy rating in a […]

Related Keywords

R Sanders Williams , Jonathanp Graham , Piper Sandler , Amgen , Morgan Stanley , Securities Exchange Commission , Gryphon Financial Partners , Mission Creek Capital Partners Inc , Warren Averett Asset Management , Wells Fargo Company , Amgen Inc , Pacifica Partners Inc , Get Rating , Exchange Commission , Directorr Sanders Williams , Averett Asset Management , Creek Capital Partners , Financial Partners , Nasdaq Amgn , Amgn , Medical , 03116210 , Boost Price Target , Oppenheimer Holdings Inc ,